Induction of anti-tumor immunity by dendritic cells transduced with FAT10 recombinant adenovirus in mice.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cellular Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cellimm.2014.11.003PMID 25461613
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention of hepatitis C virus infection and liver cancer.

  2014cited by this paper
• FAT10ylation as a signal for proteasomal degradation.

  2014cited by this paper
• FAT10, an ubiquitin-like protein, confers malignant properties in non-tumorigenic and tumorigenic cells.

  2014cited by this paper
• Diosmin abrogates chemically induced hepatocarcinogenesis via alleviation of oxidative stress, hyperproliferative and inflammatory markers in murine model.

  2013cited by this paper
• An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis

  2013cited by this paper
• Anti-angiogenic therapy for HCC.

  2012cited by this paper
• Targeted therapy for hepatocellular carcinoma: novel agents on the horizon

  2012cited by this paper
• Immunotherapeutic Approaches to Hepatocellular Carcinoma Treatment

  2012cited by this paper
• Recurrence after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis.

  2012cited by this paper
• FAT10 and NUB1L bind to the VWA domain of Rpn10 and Rpn1 to enable proteasome-mediated proteolysis

  2012cited by this paper
• Prognostic factors in hepatitis C patients with a single small hepatocellular carcinoma after radiofrequency ablation.

  2012cited by this paper
• Salvage treatment with hypofractionated radiotherapy in patients with recurrent small hepatocellular carcinoma.

  2012cited by this paper
• Increased expression of FAT10 in colon benign, premalignant and malignant epithelial neoplasms.

  2011cited by this paper
• Survival After Anatomic Resection Versus Nonanatomic Resection for Hepatocellular Carcinoma: A Meta-Analysis

  2011cited by this paper
• FAT10 Protein Binds to Polyglutamine Proteins and Modulates Their Solubility*

  2011cited by this paper
• FAT10 mediates the effect of TNF-α in inducing chromosomal instability

  2011cited by this paper
• [Accuracy of multislice computed tomography in the diagnosis of hepatocellular carcinoma in patients with cirrhosis evaluated for liver transplantation].

  2011cited by this paper
• The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model.

  2011cited by this paper
• Precisión de la tomografía multidetector en el diagnóstico de hepatocarcinoma en pacientes con cirrosis evaluados para trasplante hepático

  2011cited by this paper
• Dendritic Cells Generated in Clinical Grade Bags Strongly Differ in Immune Functionality When Compared With Classical DCs Generated in Plates

  2010cited by this paper
• FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis and TNM staging.

  2009cited by this paper
• Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L

  2009cited by this paper
• Recent Advances of Dendritic Cells (DCs)-Based Immunotherapy for Malignant Gliomas

  2009cited by this paper
• Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon

  2008cited by this paper
• Appropriate Timing of CD40 Ligation for RNA‐Pulsed DCs to Induce Antitumor Immunity

  2008cited by this paper
• Mechanisms, biology and inhibitors of deubiquitinating enzymes.

  2007cited by this paper
• p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers

  2006cited by this paper
• Expanded criteria for liver transplantation in patients with hepatocellular carcinoma.

  2006cited by this paper
• FAT10, a gene up-regulated in various cancers, is cell-cycle regulated

  2006cited by this paper
• The UBA Domains of NUB1L Are Required for Binding but Not for Accelerated Degradation of the Ubiquitin-like Modifier FAT10*

  2006cited by this paper
• Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival.

  2006cited by this paper
• The Molecular Diagnosis of Hepatitis B Virus-Associated Hepatocellular Carcinoma

  2006cited by this paper
• A prospective, randomized, multi‐centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma

  2006cited by this paper
• Insights into E3 ligase activity revealed by a SUMO–RanGAP1–Ubc9–Nup358 complex

  2005cited by this paper
• Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.

  2005cited by this paper
• Molecular features of human ubiquitin-like SUMO genes and their encoded proteins.

  2002cited by this paper
• Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin–proteasome degradation

  2001cited by this paper
• Proteasome inhibitors as anti-cancer agents.

  2000cited by this paper
• Structure determination of the small ubiquitin-related modifier SUMO-1.

  1998cited by this paper

• NUB1 and FAT10 Proteins as Potential Novel Biomarkers in Cancer: A Translational Perspective

  2021cites this paper
• Clinicopathological significance of human leukocyte antigen F-associated transcript 10 expression in colorectal cancer

  2019cites this paper
• Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials

  2017cites this paper
• The ubiquitin-proteasome system and its potential application in hepatocellular carcinoma therapy.

  2016cites this paper